GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,000 | 0.0% | 16,140 | +45.7% | 0.00% | – |
| Q2 2023 | $61,000 | +52.5% | 11,076 | +22.0% | 0.00% | – |
| Q1 2023 | $40,000 | -20.0% | 9,079 | -29.5% | 0.00% | – |
| Q4 2022 | $50,000 | +35.1% | 12,875 | +85.6% | 0.00% | – |
| Q3 2022 | $37,000 | -14.0% | 6,936 | +4.9% | 0.00% | – |
| Q2 2022 | $43,000 | -35.8% | 6,613 | -26.9% | 0.00% | – |
| Q1 2022 | $67,000 | -40.7% | 9,043 | -44.0% | 0.00% | – |
| Q4 2021 | $113,000 | -21.0% | 16,162 | +183.6% | 0.00% | – |
| Q3 2021 | $143,000 | +21.2% | 5,698 | +30.2% | 0.00% | – |
| Q2 2021 | $118,000 | -33.7% | 4,376 | -29.9% | 0.00% | – |
| Q1 2021 | $178,000 | +196.7% | 6,242 | +192.9% | 0.00% | – |
| Q4 2020 | $60,000 | +400.0% | 2,131 | +432.8% | 0.00% | – |
| Q3 2020 | $12,000 | +50.0% | 400 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,279,484 | $31,379,244 | 4.86% |
| GREAT POINT PARTNERS LLC | 1,022,537 | $3,875,415 | 0.71% |
| Artal Group S.A. | 2,814,191 | $10,666 | 0.46% |
| PFM Health Sciences, LP | 2,514,443 | $9,529,739 | 0.45% |
| Yiheng Capital Management, L.P. | 1,666,181 | $6,314,826 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 356,740 | $1,352,045 | 0.26% |
| EcoR1 Capital, LLC | 2,046,867 | $7,757,626 | 0.26% |
| Bellevue Group AG | 3,617,080 | $13,708,733 | 0.22% |
| SVB FINANCIAL GROUP | 25,034 | $94,879 | 0.18% |
| CORNERCAP INVESTMENT COUNSEL INC | 37,681 | $142,811 | 0.03% |